Margaret T. May

Margaret T. May is Professor of Medical Statistics at the University of Bristol, and specialises in prognostic modelling and HIV epidemiology.

May has a master's degree from the University of Cambridge, and a master's degree and PhD from the University of Bristol.

Selected publications

 * May, M, Gompels, M & Sabin, C, 2010, ‘Impact on life expectancy of late diagnosis and treatment of HIV-1 infected individuals: UK CHIC’. in: Tenth International Congress on Drug Therapy in HIV Infection Glasgow, UK.
 * May, M, Boulle, A, Phiri, S, Messou, E, Myer, L, Wood, R, Keiser, O, Sterne, J, Dabis, F & Egger, M, 2010, ‘Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes’. The Lancet, vol 376., pp. 449 – 457
 * Ingle, S, Fairall, L, Timmerman, V, Bachmann, M, Sterne, JAC, Egger, M, May, M & Southern, AI-, 2010, ‘Competing Risks Analysis of Pre-Treatment Mortality and Probability of Starting ART in Patients Enrolled in the Free State ARV Program, South Africa’. in: Abstract 7, 14th International Workshop on HIV, Sitges, Spain., pp. 5 – 6
 * May, M, Emond, A & Crawley, E, 2010, ‘Phenotypes of Chronic Fatigue Syndrome in Children and Young People’. Archives of Disease in Childhood, vol 95., pp. 245 – 249
 * Sterne, J, May, M, Costagliola, D, Wolf, Fd, Phillips, A, Harris, R, Funk, M, Geskus, R, Gill, J, Dabis, F, Miro, J, Justice, A, Ledergerber, B, Fatkenheuer, G, Hogg, R, Monforte, Ad, Saag, M, Smith, C, Staszewski, S, Egger, M, Cole, S &, 2009, ‘Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies’. The Lancet, vol 373., pp. 1352 – 1363
 * Taffe, P & May, M, 2008, ‘A joint back calculation model for the imputation of the date of HIV infection in a prevalent cohort’. Stat Med, vol 27 (23)., pp. 4835 – 4853
 * Ebrahim, S, May, M, McCarron, P, Frankel, S, Smith, GD & Yarnell, J, 2001, ‘Sexual intercourse and risk of ischaemic stroke and coronary heart disease: the Caerphilly study’. in: Societies, Individuals and Populations - Joint conference of the Society for Social Medicine and the International Epidemiological Association European Group, Oxford.
 * Bleiber, G, May, M, Martinez, R, Meylan, P, Ott, J, Beckmann, J, Telenti, A & Cohort, StSH, 2005, ‘Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progression’. Journal of Virology, vol 79 (20)., pp. 12674 – 12680
 * Gill, J, May, M, Lewden, C, Saag, M, Mugavero, M, Reiss, P, Ledergerber, B, Mocroft, A, Harris, R, Fux, C, Justice, A, Costagliola, D, Casabona, J, Hogg, R, Khaykin, P, Lampe, F, Vehreschild, J & Sterne, J, 2010, ‘Causes of death in HIV-1 infected patients treated with antiretroviral therapy 1996-2006: collaborative analysis of 13 HIV cohort studies’. Clinical Infectious Diseases, vol 50., pp. 1387 – 1396